Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Glover, Matthew ^a   Buxton, Martin ^a   Guthrie, Susan ^b   Hanney, Stephen ^a   Pollitt, Alexandra ^b   Grant, Jonathan ^b,c  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b RAND CORPORATION   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; Medical research charities; Medical research investment; QALYs; Rate of return; Research payback; Time lags; Value of health

Indexed keywords

ARTICLE; BREAST CANCER; CALCULATION; CANCER RESEARCH; CANCER SCREENING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; FUNDING; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; INCIDENCE; INTESTINE CANCER; MEDICAL RESEARCH; MEDLINE; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PROSTATE CANCER; PUBLICATION; QUALITY ADJUSTED LIFE YEAR; SMOKING; THERAPY; UNITED KINGDOM; UTERINE CERVIX CANCER; WELLBEING; WORKING TIME; CANCER PATIENT; HEALTH CARE; HEALTH PROGRAM; OUTCOME ASSESSMENT; SCREENING TEST; SENSITIVITY ANALYSIS; TIME SERIES ANALYSIS; COST; COST BENEFIT ANALYSIS; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH STATUS; NEOPLASMS; NON PROFIT ORGANIZATION; ORGANIZATION AND MANAGEMENT; PREVENTION AND CONTROL; SMOKING CESSATION;

BIOMEDICAL RESEARCH; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FOUNDATIONS; GREAT BRITAIN; HEALTH STATUS; HUMANS; INCIDENCE; NEOPLASMS; PUBLIC SECTOR; QUALITY-ADJUSTED LIFE YEARS; RESEARCH SUPPORT AS TOPIC; SMOKING; SMOKING CESSATION;

EID: 84902460681     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-12-99     Document Type: Article

References (60)

1. Editorial Unknown quantities. Nature 2010, 465:665-666. Editorial.
2. Buxton M, Hanney S, Jones T. Estimating the economic value to societies of the impact of health research: a critical review. Bull World Health Organ 2004, 82:733-739. 2623029, 15643793.
3. Health Economics Research Group, Office of Health Economics, RAND Europe Medical Research: What's it Worth? Estimating the economic benefits from medical research in the UK 2008, London: UK Evaluation Forum, [http://www.wellcome.ac.uk/stellent/groups/corporatesite/@sitestudioobjects/documents/web_document/wtx052110.pdf, Accessed: January 2014], Health Economics Research Group, Office of Health Economics, RAND Europe.
4. Mushkin S. Biomedical Research: Costs and Benefits 1979, Cambridge, MA: Ballinger.
5. Drummond MF, Davies LM, Ferris FL. Assessing the costs and benefits of medical research: the diabetic retinopathy study. Soc Sci Med 1992, 34:973-981. 10.1016/0277-9536(92)90128-D, 1631610.
6. Funding First Exceptional Returns: The Economic Value of America's Investment in Medical Research 2000, New York: Lasker Foundation, [http://www.laskerfoundation.org/media/pdf/exceptional.pdf, Accessed: January 2014], Funding First.
7. Murphy KM, Topel R. The economic value of medical research 1998, New York: Lasker Foundation, [http://www.laskerfoundation.org/pdf/economicvalue.pdf, Accessed: January 2104].
8. Access Economics Exceptional Returns: The Value of Investing in Health R&D in Australia 2003, Canberra: Access Economics, [http://www.asmr.org.au/Except.pdf, Accessed: January 2014], Access Economics.
9. Access Economics Exceptional Returns: The Value of Investing in Health R&D in Australia II 2008, Canberra: Access Economics, [http://www.asmr.org.au/ExceptII08.pdf, Accessed: January 2014], Access Economics.
10. Deloitte Access Economics Returns on NHMRC funded Research and Development 2011, Canberra: Deloitte Access Economics, [http://www.asmr.org.au/NHMRCReturns.pdf, Accessed: January 2014], Deloitte Access Economics.
11. Litchenberg FR. The expanding pharmaceutical arsenal in the war on cancer. NBER Working Paper Series 2004, Paper No. w10328.
12. Sun EC, Jena AP, Lakdawalla DN, Reyes CM, Philipson TJ, Goldman DP. An economic evaluation of the war on cancer. NBER Working Paper Series 2009, Paper No. 15574.
13. Lakdawalla DN, Sun EC, Jena AB, Reyes CM, Goldman DP, Philipson TJ. An economic evaluation of the war on cancer. J Health Econ 2010, 29:333-346. 10.1016/j.jhealeco.2010.02.006, 20363520.
14. Buxton M, Hanney S. How can payback from health services research be assessed?. J Health Serv Res Policy 1996, 1:35-43.
15. Hanney S, Mugford M, Grant J, Buxton M. Assessing the benefits of health research: lessons from research into the use of antenatal corticosteroids for the prevention of neonatal respiratory distress syndrome. Soc Sci Med 2005, 60:937-947. 10.1016/j.socscimed.2004.06.038, 15589665.
16. Wooding S, Hanney S, Buxton M, Grant J. Payback arising from research funding: evaluation of the Arthritis Research Campaign. Rheumatology 2005, 44:1145-1156. 10.1093/rheumatology/keh708, 16049052.
17. Wooding S, Hanney S, Pollitt A, Buxton M, Grant J. Project Retrosight: Understanding the Returns from Cardiovascular and Stroke Research 2011, Cambridge: RAND Europe, [http://www.rand.org/pubs/monographs/MG1079.html, Accessed: January 2014].
18. Wooding S, Pollitt A, Castle-Clarke S, Cochrane G, Diepeveen S, Guthrie S, Hortvitz-Lennon M, Larivière V, Ni Chonaill S, O'Brien C, Olmsted S, Schultz D, Winpenny E, Pincus HA, Grant J. Mental Health Retrosight. Understanding the Returns from Research. (lessons from schizophrenia). Policy Report 2013, Cambridge: RAND Europe, [http://www.rand.org/randeurope/research/projects/mental-health-retrosight.html, Accessed: January 2014].
19. Johnston SC, Rootenberg JD, Katrak S, Smith WS, Elkins JS. Effect of a US National Institutes of Health programme of clinical trials on public health and costs. Lancet 2006, 367:1319-1327. 10.1016/S0140-6736(06)68578-4, 16631910.
20. Cancer Research UK Medical Research and the Spending Review 2010, [http://info.cancerresearchuk.org/prod_consump/groups/cr_common/@nre/@pol/documents/generalcontent/cr_048533.pdf, Accessed: 20 May 2012], Cancer Research UK.
21. Association of Medical Research Charities Written Submission to the Comprehensive Spending Review 2010, [http://www.amrc.org.uk/publications/submission-department-business-innovation-and-skills-part-comprehensive-spending-review. Accessed: January 2014], Association of Medical Research Charities.
22. Academy of Medical Sciences Initial Response to the Spending Review Consultation 2010, [http://www.acmedsci.ac.uk/download.php?file=/images/publication/128393883472.pdf, Accessed: May 2012], Academy of Medical Sciences.
23. European Medical Research Councils White Paper II: A Stronger Biomedical Research for a Better European Future 2011, Strasbourg: European Science Foundation, European Medical Research Councils.
24. Guthrie S, Grant J, Hanney S, Pollitt A. Investigating time lags and attribution in the translation of cancer research: A case study approach 2014, Cambridge: RAND Europe.
25. Dawson G, Lucocq B, Cottrell R, Lewison G. Mapping the Landscape: National Biomedical Research Outputs 1988-95 1998, London: Wellcome Trust.
26. Wellcome Trust Putting NHS Research on the Map: An Analysis of Scientific Publications in England, 1990-97 2001, London: Wellcome Trust, Wellcome Trust.
27. Capewell S, Critchley J, Unal B. IMPACT: a Validated, Comprehensive Coronary Heart Disease Model. Overview and Technical Appendices 2007, Liverpool: University of Liverpool.
28. CRUK statistics. [http://www.cancerresearchuk.org/, Accessed December 2013].
29. ONS statistics, MB1 series no 32. [http://www.ons.gov.uk, Accessed December 2013].
30. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JWW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008, 44:1345-1389. 10.1016/j.ejca.2007.12.015, 18280139.
31. National Cancer Intelligence Network. Incidence Stomach Cancer Engl 1998-2007, [http://www.ncin.org.uk/publications/data_briefings/incidence_of_stomach_cancer_in_england Accessed: February 2014].
32. Bine Kjøller B, Raaschou-Nielsen O, Sørensen M, Frederiksen K, Christensen J, Tjønneland A, Overvad K, Chapelon FC, Nagel G, Chang-Claude J, Bergmann MM, Boeing H, Trichopoulos D, Trichopoulou A, Oikonomou E, Berrino F, Palli D, Tumino R, Vineis P, Panico S, Peeters PHM, Bueno-de-Mesquita HB, Kiemeney L, Gram IT, Braaten T, Lund E, Gonzalez CA, Berglund G, Allen N, Roddam A, et al. Tobacco smoke and bladder cancer-in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2006, 119:2412-2416. 10.1002/ijc.22169, 16894557.
33. Independent UK Panel on Breast Cancer Screening The benefits and harms of breast cancer screening: an independent review. Lancet 2012, 380:1778-1786. Independent UK Panel on Breast Cancer Screening.
34. Libby G, Brewster DH, McClements PL, Carey FA, Black RJ, Birrell J, Fraser CG, Steele RJC. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer 2012, 107:255-259. 10.1038/bjc.2012.277, 3394992, 22735907.
35. Canfell K, Freddy S, Beral V. Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Med J Aust 2006, 185:482.
36. CancerStats - Survival. [http://publications.cancerresearchuk.org/downloads/Product/CS_CS_SURVIVAL.pdf, Accessed: December 2013].
37. Cancer survival in England - patients diagnosed 2005-2009 and followed up to 2010. [http://www.ons.gov.uk/ons/rel/cancer-unit/cancer-survival/2005-2009--followed-up-to-2010/stb-cancer-survival--2005-09-and-followed-up-to-2010.html. Accessed December 2013].
38. Godfrey C, Shezad A, Parrott S, Pickett K. Economic model of adult smoking related costs and consequences for England, October 2010 (Revised April 2011) 2011, York: Public Health Research Consortium Project Report, [http://phrc.lshtm.ac.uk/papers/PHRC_A4-06_Final_Report.pdf].
39. Kind P, Hardman G, Macran S. UK population norms for EQ-5D. Discussion paper 182 1999, York: University of York, [http://www.york.ac.uk/media/che/documents/papers/discussionpapers/CHE%20Discussion%20Paper%20172.pdf, Accessed: January 2014].
40. Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N. Liquid-based cytology in cervical screening, an updated rapid and systematic review and economic analysis. Health Technol Assess 2004, 8:1-78. Table 21.
41. Whyte S, Chilcott J, Cooper K, Essat M, Stevens J, Wong R, Kalita N. Reappraisal of the options for colorectal cancer screening. Full report for the NHS Bowel Cancer Screening Programme. 2011, Sheffield: ScHARR, University of Sheffield, Table 4.2.1.
42. Pharoah PD, Sewell B, Fitzsimmons D, Bennett HS, Pashayan N. Cost effectiveness of the NHS breast screening programme: life table model. BMJ 2013, 346:f2618. 10.1136/bmj.f2618, 3649817, 23661112.
43. National Institute for Health and Clinical Excellence. Colorectal Cancer The Diagnosis and Management of Colorectal Cancer. CG 131 2011, [http://guidance.nice.org.uk/CG131, Accessed: December 2013], National Institute for Health and Clinical Excellence. Colorectal Cancer.
44. National Institute for Health and Clinical Excellence Early and Locally Advanced Breast Cancer: Diagnosis and Treatment. CG 80 2009, [http://guidance.nice.org.uk/CG80, Accessed: December 2013], National Institute for Health and Clinical Excellence.
45. National Institute for Health and Clinical Excellence Advanced Breast Cancer: Diagnosis and Treatment. CG 81 2009, [http://publications.nice.org.uk/advanced-breast-cancer-cg81, Accessed: December 2013], National Institute for Health and Clinical Excellence.
46. National Institute for Health and Clinical Excellence Prostate cancer: Diagnosis and Treatment. CG58 2008, [http://publications.nice.org.uk/prostate-cancer-cg58, Accessed: December 2013], National Institute for Health and Clinical Excellence.
47. Health and Social Care Information Centre. 2012, England: Statistics on Smoking, Table 2.2 [http://www.hscic.gov.uk/catalogue/PUB07019/smok-eng-2012-rep.pdf, Accessed: February 2014].
48. Hospital Episodes Statistics. [http://www.hscic.gov.uk/hes, Accessed: January 2014].
49. Health and Social Care information Centre. [http://www.hscic.gov.uk/, Accessed: January 2014].
50. PSSRU, Unit Costs of Health and Social Care 2012. [http://www.pssru.ac.uk/project-pages/unit-costs/2012/, Accessed: January 2014].
51. Guide to the methods of technology appraisal 2008. [http://www.nice.org.uk/aboutnice/howwework/devnicetech/GuideToMethodsTechnologyAppraisal2008.jsp, Accessed February 2014].
52. Guide to the methods of technology appraisal 2013. [http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013-pmg9, Accessed: January 2014].
53. World Health Organisation Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics for Health 2001, [http://whqlibdoc.who.int/publications/2001/924154550x.pdf, Accessed: May 2014], World Health Organisation.
54. Grant J, Cottrell R, Cluzeau F, Fawcett G. Evaluating " payback" on biomedical research from papers cited in clinical guidelines: applied bibliometric study. BMJ 2000, 320:1107-1111. 10.1136/bmj.320.7242.1107, 27352, 10775218.
55. Murray CJL, Richards MA, Newton JN, Fenton KA, Anderson HR, Atkinson C, Bennett D, Bernabé E, Blencowe H, Bourne R, Braithwaite T, Brayne C, Bruce NG, Brugha TS, Burney P, Dherani M, Dolk H, Edmond K, Ezzati M, Flaxman AD, Fleming TD, Freedman G, Gunnell D, Hay RJ, Hutchings SJ, Ohno SL, Lozano R, Lyons RA, Marcenes W, Naghavi M, et al. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013, 381:997-1020. 10.1016/S0140-6736(13)60355-4, 23668584.
56. Department of Health An Audit of the Impact of the Department of Health's Regulations upon Businesses. Final Report September 2013. [https://www.gov.uk/government/publications/department-of-health-regulations-impact-on-business. Accessed: January 2014], Department of Health.
57. The National Cancer Research Institute. [http://www.ncri.org.uk].
58. The Centre for Science and Technology Studies. [http://www.socialsciences.leiden.edu/cwts/].
59. Her Majesties Treasury GDP data. [http://www.hm-treasury.gov.uk/data_gdp_fig.htm].
60. The National Institute of Health price index. [http://officeofbudget.od.nih.gov/gbiPriceIndexes.html].